Purchase Order 36C26326P0208

Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis VA) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of January 20, 2026. This contract, awarded on January 16, 2026, carries no set-aside designation and represents Edwards Lifesciences' specialized supply of advanced cardiovascular medical devices to the Department of Veterans Affairs. The award is structured as a straightforward purchase order rather than a larger indefinite delivery vehicle, though it aligns with Edwards Lifesciences' extensive contracting relationship with the VA system.

This contract exemplifies Edwards Lifesciences' critical role as a sole-source supplier of specialized cardiac technologies to the VA healthcare system. The company, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, has secured over 200 federal prime contract awards since 2025, predominantly from the Department of Veterans Affairs across multiple Veterans Integrated Service Networks. Beyond individual purchase orders, Edwards Lifesciences maintains two significant indefinite delivery contracts with the VA totaling $7.45 million—including a $6.5 million five-year consignment arrangement with VISN 21 and a $950,000 five-year vehicle with VISN 15—establishing the company as the primary framework supplier of advanced cardiovascular devices supporting veteran cardiac care across the VA system.